San Francisco -- IMS Health, a Connecticut-based developer of web-based software for life sciences organizations, said on Tuesday it has acquired DecisionView, a San Francisco-based developer of software designed to help life sciences organizations plan and track patient enrollment for clinical trials. Financial terms of the deal were not disclosed. DecisionView will become part of IMS's Healthcare Value Solutions business. "Through this acquisition, we will enhance clinical trial productivity – transforming the way patient studies are planned and executed," said Andrew Kress, the senior vice president of IMS Healthcare Value Solutions.
http://www.imshealth.com
http://www.decisionview.com
http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c033208c22a/?vgnextoid=e5df509d881e6310VgnVCM10000076192ca2RCRD&vgnextchannel=3e382115cc4be210VgnVCM10000071812ca2RCRD&vgnextfmt=default